Antihistamines, Amantadine and Evolution of COVID-19

Recruiting now

Conditions studied: COVID-19

In brief

The rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.

Key facts

Study ID

NCT05504057

Run by

Consorci Sanitari de Terrassa

People needed

140660

Starts

2020-03-01

Expected to finish

2028-02-24

Last updated by the study team

2026-04-03

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

Where it is running

• Hospital de Terrassa — Terrassa, Barcelona, Spain (enrolling)
• Hospital of Terrassa — Terrassa, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.